Tuesday’s announcement that scientists had found a noncontroversial way to make cells equivalent to human embryonic stem cells did not just change the scientific and ethical landscape. It generated economic and geopolitical tremors through California, New York and about half a dozen other states that have invested — in some cases heavily — in embryonic stem cell programs and research centers.
Office of Strategic Communication